We report a case of an immunocompetent Peruvian patient from the Andes with a one-month history of meningoencephalitis. Cryptococcus gattii was identified from a cerebrospinal fluid culture through assimilation of D-proline and D-tryptophan as the single nitrogen source. Initially, the patient received intravenous antifungal therapy with amphotericin B. The patient was discharged 29 days after hospitalization and continued with oral fluconazole treatment for ten weeks. During this period, the patient showed clinical improvement with slight right-side residual weakness. Through this case report, we confirm the existence of this microorganism as an infectious agent in Peru.
|Original language||American English|
|Number of pages||3|
|Journal||Revista da Sociedade Brasileira de Medicina Tropical|
|State||Published - 1 Jan 2010|
Gutierrez, E. L., Valqui, W., Vilchez, L., Evangelista, L., Crispin, S., Tello, M., Ñavincopa, M., Béjar, V., Gonzáles, J., & Ortega-Loayza, A. G. (2010). Cryptococcus gattii meningoencephalitis in an HIV-negative patient from the Peruvian Andes. Revista da Sociedade Brasileira de Medicina Tropical, 469-471. https://doi.org/10.1590/S0037-86822010000400029